Rosalind Advisors’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$11.3M	Hold	1,218,700	–	–	5.36%	4
2025 Q1	$8.93M	Buy	1,218,700 +90,000	+8%	+$660K	4.34%	8
2024 Q4	$9.64M	Buy	1,128,700 +243,700	+28%	+$2.08M	4.93%	7
2024 Q3	$7.7M	Buy	885,000 +135,000	+18%	+$1.17M	4.93%	10
2024 Q2	$5.13M	Buy	+750,000	New	+$5.13M	3.95%	10